Form D · Private Equity Fund
Angiocrine Fund, LP
Nashville, TN · CIK 0001566838
Offering snapshot reported Jan 17, 2013 · SEC filing
- Reported sold
- $1.35M Offering amount: $4.3M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jan 2, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2013 | Initial | $1,350,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190444
Source: Form D, filed Jan 17, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Angio C Management, Llc | Promoter |
| W Bradley Daniel | Executive |
| Jeffrey L Port | Executive |
| Angelia Van Vranken | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
112 2 Nd Avenue North
Nashville, TN, 37201
Nashville, TN, 37201